Fluorokinolonbruk i sykehjem

Tidsskrift for den Norske Laegeforening

Volumn 130, Issue 20, 2010, Pages 2022-2024

  Fagan, Mark ^a,b   Skotheim, Stian Bøe ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b Tromøy Legesenter ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; QUINOLONE DERIVATIVE; URINARY TRACT ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MICROBIOLOGY; NORWAY; NURSING HOME; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; NORWAY; NURSING HOMES; RESPIRATORY TRACT INFECTIONS; URINARY TRACT INFECTIONS;

EID: 78049447858     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.0560     Document Type: Article

References (28)

1. World Health Organization Report on Infectious Diseases 2000. Overcoming antimicrobial resistance. Genève: WHO, 2000. www.who.int/infectious-disease-report/2000/index.html (6.4.2009).
2. The European Antimicrobial Resistance Surveillance System. www.rivm.nl/earss/ (6.4.2009).
3. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
4. NORM/NORM-VET 2007. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo: Veterinærinstituttet, 2008.
5. Legemiddelforbruket i Norge. www.legemiddelforbruk.no (6.4.2009).
6. Smittevernloven - håndbok. Bruk av antibiotika i sykehus. Oslo: Statens helsetilsyn, 2001. http://www.helsedirektoratet.no/vp/multimedia/archive/00003/ik-2737_3321a.pdf (6.4.2009).
7. Kompetansesenter for rasjonell antibiotikabruk i Helse Øst. www.aus.no/modules/module_123/proxy.asp?D=2&C=555&I=5682&mids=844a1017 (6.4.2009).
8. Veiledning i bruk av antibiotika for Helse Vest. http://antibiotika.ihelse.net (6.4.2009).
9. Lindbæk M, red. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Oslo: Helsedirektoratet, 2008. www.helsebiblioteket.no/microsite/antibiotikaretningslinjer (6.4.2009).
10. Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
11. Colodner R, Rock W, Chazan B et al. Risk factors for the development of extended-spectrum betalactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004; 23: 163-7.
12. Blumberg HM, Rimland D, Carroll DJ et al. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991; 163: 1279-85.
13. Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
14. Kuijper EJ, Coignard B, Tüll P et al. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 (suppl 6): 2-18.
15. Denève C, Janoir C, Poilane I et al. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 2009; 33 (suppl 1): S24-8.
16. Litleskare I, Blix HS, Rønning M. Antibiotikaforbruk i Norge. Tidsskr Nor Legeforen 2008; 128: 2324-9.
17. Alexopoulou A, Dourakis SP, Mantzoukis D et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med 2008; 19: 505-10.
18. Ebbesen J, Buajordet I, Erikssen J et al. Drugrelated deaths in a department of internal medicine. Arch Intern Med 2001; 161: 2317-23.
19. Bucher A, Sorknes N, Lundquist K. Infeksjoner og antibiotikabehandling ved sykehjem. Tidsskr Nor Lægeforen 2001; 7: 827-30.
20. Tobiassen T, Berild D, Hjortdahl P. Bruk av systemiske antibiotika ved et norsk sykehjem. Tidsskr Nor Lægeforen 2002; 24: 2376-8.
21. Blix HS, Røed J, Sti MO. Large variation in antibacterial use among Norwegian nursing homes. Scand J Infect Dis 2007; 39: 536-41.
22. Lomas J, Anderson GM, Domnick-Pierre K et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989; 321: 1306-11.
23. Munck AP, Gahrn-Hansen B, Søgaard P et al. Long-lasting improvement in general practitioners' prescribing of antibiotics by means of medical audit. Scand J Prim Health Care 1999; 17: 185-90.
24. Cizman M, Srovin T, Pokorn M et al. Analysis of the causes and consequences of decreased antibiotic consumption over the last 5 years in Slovenia. J Antimicrob Chemother 2005; 55: 758-63.
25. Statistisk sentralbyrå. http://statbank.ssb.no/statistikkbanken/ (6.4.2009).
26. Statens legemiddelverk. www.legemiddelverket. no/templates/InterPage___80668.aspx (6.4.2009).
27. European Antimicrobial Resistance Surveillance System. http://www.rivm.nl/earss/database/ (6.4.2009).
28. Berild D, Mohseni A, Diep LM et al. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J Antimicrob Chemother 2006; 57: 326-30.